Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > 18 trading days left in the quarter.

<< Previous

Bullboard Posts

Next >>

Comment by cool888on Mar 05, 2021 5:40pm

155 Views

Post# 32734316

RE:18 trading days left in the quarter.

Trippedstocks wrote:
and supposedly we are supposed to see:

Q1-21 Submit FDA IND for Phase 2 study for CBD in AIH

Q1-21 Psilocybin oral thin film scale-up

Q1-21 Psilocybin research results in TBI (Concussion)

Q1-21 Begin Phase 1 study - Psilocybin in Meth Disorder

As well as the meeting agenda/info/proxy materials

could be an exciting and interesting 3 weeks... Or a disappointing 3 weeks. We shall see.